Evidence
The liver is a complex immunological organ. It has both immunogenic and tolerogenic capacity. Tolerogenic potential of human liver with its protective firewalls is required to guard the body against the continuous influx of microbial product from the gut via the sinusoids and biliary tree. Immunotolerance and anergic state is maintained by a combined effort of both immune cells, parenchyma cells, epithelial and endothelial cells. Despite this, an unknown trigger can ignite the pathway towards breakdown in hepatic tolerance leading to autoimmune liver diseases. The human liver contains different subsets of effector lymphocytes that are kept in check by a subpopulation of T cells known as Regulatory T cells (Treg). The balance of effector and regulatory lymphocytes generally determines the outcome of hepatic inflammation: resolution, fulminant hepatitis, or chronic active hepatitis. Dissecting this pathology using the current technological advances is crucial to develop curative immune based therapies.
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Effector and regulatory T cells balance in inflamed human livers
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Lipopolysaccharide, arbiter of the gut-liver axis, modulates hepatic cell pathophysiology in alcoholism
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
- Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- The effects of simvastatin-loaded nanoliposomes on human multilineage liver fibrosis microtissue
- IFN-β Overexpressing Adipose-Derived Mesenchymal Stem Cells Mitigate Alcohol-Induced Liver Damage and Gut Permeability
- Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
- The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC
- Amplification of autoimmune organ damage by NKp46-activated ILC1
- Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl-Hydrocarbon Receptors Pathway in Non-Alcoholic Steatohepatitis Mice
- Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells
- Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
- SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro
- Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway
- Decrease in UCP1 by sustained high lipid promotes NK cell necroptosis to exacerbate nonalcoholic liver fibrosis
- Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice
- Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
- Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease
- Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study
- Development of an alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell-derived liver organoids
- Development of an alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell-derived liver organoids
- Musculus senhousei peptides alleviated alcoholic liver injury via the gut-liver axis
- Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity
- Pyronaridine Inhibited MUC5AC Mucin Gene Expression by Regulation of Nuclear Factor Kappa B Signaling Pathway in Human Pulmonary Mucoepidermoid Cells
- Hepatic miR-363 promotes non-alcoholic fatty liver disease by suppressing INSIG1
- Haloacetamides disinfection by-products, a potential risk factor for nonalcoholic fatty liver disease
- Apolipoprotein H deficiency exacerbates alcohol-induced liver injury via gut Dysbiosis and altered bile acid metabolism
- FGL1 and FGL2: emerging regulators of liver health and disease
- A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Enhanced In Vitro Recapitulation of In Vivo Liver Regeneration by Co-Culturing Hepatocyte Organoids with Adipose-Derived Mesenchymal Stem Cells, Alleviating Steatosis and Apoptosis in Acute Alcoholic Liver Injury
- Enhanced In Vitro Recapitulation of In Vivo Liver Regeneration by Co-Culturing Hepatocyte Organoids with Adipose-Derived Mesenchymal Stem Cells, Alleviating Steatosis and Apoptosis in Acute Alcoholic Liver Injury
- Effects of Marine Natural Products on Liver Diseases
- A deep-learning-based model for assessment of autoimmune hepatitis from histology: AI(H)
- Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis: One sentence summary: Peroxynitrite-mediated Treg IL-2R nitration impacts on multiple sclerosis
- Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine
- Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort
- Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook
- Central nervous system-associated macrophages modulate the immune response following stroke in aged mice
- Central nervous system-associated macrophages modulate the immune response following stroke in aged mice
- From dendritic cells to inflammatory bowel disease
- Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease
- Obliteration of liver sinusoids through platelet aggregates associated to extramedullary haematopoiesis in myeloid neoplasms
- Assessment of Mitochondrial Respiration During Hypothermic Storage of Liver Biopsies Following Normothermic Machine Perfusion
- p27 specifically decreases in squamous carcinoma, and mediates NNK-induced transformation of human bronchial epithelial cells
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- The role and mechanism of pyroptosis and potential therapeutic targets in non-alcoholic fatty liver disease (NAFLD)
- Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease
- The potential role of Akkermansia muciniphila in liver health
- Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption
- Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease
- From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers
Evidence Blueprint
Effector and regulatory T cells balance in inflamed human livers
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Effector and regulatory T cells balance in inflamed human livers
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Angiocrine signaling in sinusoidal homeostasis and liver diseases
- Lipopolysaccharide, arbiter of the gut-liver axis, modulates hepatic cell pathophysiology in alcoholism
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease
- The impact of G-CSF on mouse immune cells in alcoholic liver disease, focusing on variations in T cells and their subsets
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
- Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
- Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
- Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives
- Vitamin D/Vitamin D receptor pathway in nonalcoholic fatty liver disease
- Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Crosstalk in extrahepatic and hepatic system in NAFLD/NASH
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Trimethylamine N-oxide Induces Non-alcoholic Fatty Liver Disease by Activating the PERK Signaling Pathway
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease
- Bone marrow monocytes sustain NK cell-poiesis during non-alcoholic steatohepatitis
- Allergen-encapsulating Nanoparticles Reprogram Pathogenic Allergen-Specific Th2 Cells to Suppress Food Allergy
- Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease
- Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity
- Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease
- Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells
- Cerebral malaria pathogenesis: Dissecting the role of CD4+ and CD8+ T-cells as major effectors in disease pathology
- Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- The effects of simvastatin-loaded nanoliposomes on human multilineage liver fibrosis microtissue
- IFN-β Overexpressing Adipose-Derived Mesenchymal Stem Cells Mitigate Alcohol-Induced Liver Damage and Gut Permeability
- Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants
- Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
- Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model
- Osr1-mediated mesothelial transition of liver mesenchymal cells exacerbates fibrotic liver damage
- Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
- Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
- Recent Advances in Mesenchymal Stem/Stromal Cell-Based Therapy for Alcohol-Associated Liver Disease and Non-alcoholic Fatty Liver Disease
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Interleukins in liver disease treatment
- Giant mitochondria in human liver disease
- The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC
- Amplification of autoimmune organ damage by NKp46-activated ILC1
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Starvation in Mice Induces Liver Damage Associated with Autophagy
- Antifibrotic activity of carbon quantum dots in a human in vitro model of non-alcoholic steatohepatitis using hepatic stellate cells
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Immunobiotic Bacteria Attenuate Hepatic Fibrosis through the Modulation of Gut Microbiota and the Activation of Aryl-Hydrocarbon Receptors Pathway in Non-Alcoholic Steatohepatitis Mice
- Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells
- Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
- The double roles of T cell-mediated immune response in the progression of MASLD
- Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
- Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice
- Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity
- Elucidating the role of intrinsic adenosine A1 receptors in acute alcoholism using human induced pluripotent stem cell-derived hepatocytes
- Effect of calcium-independent phospholipase A2 on the expression of glycerol 3-phosphate dehydrogenase in human non-alcoholic fatty liver disease cells
- SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro
- Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis
- Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway